142 related articles for article (PubMed ID: 1163503)
41. The efficacy of dietary therapy for phenylketonuria.
Hanley WB; Linsao LS; Netley C
Can Med Assoc J; 1971 Jun; 104(12):1089-91. PubMed ID: 5104016
[TBL] [Abstract][Full Text] [Related]
42. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
[TBL] [Abstract][Full Text] [Related]
43. Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria.
Pietz J; Landwehr R; Kutscha A; Schmidt H; de Sonneville L; Trefz FK
J Pediatr; 1995 Dec; 127(6):936-43. PubMed ID: 8523192
[TBL] [Abstract][Full Text] [Related]
44. Electroencephalography in holoprosencephaly: findings in children without epilepsy.
Hahn JS; Delgado MR; Clegg NJ; Sparagana SP; Gerace KL; Barkovich AJ; Olson DM
Clin Neurophysiol; 2003 Oct; 114(10):1908-17. PubMed ID: 14499753
[TBL] [Abstract][Full Text] [Related]
45. Phenylketonuria and its variants: observations on intellectual functioning.
Netley C; Hanley WB; Rudner HL
Can Med Assoc J; 1984 Oct; 131(7):751-5. PubMed ID: 6478363
[TBL] [Abstract][Full Text] [Related]
46. Visual evoked potentials in phenylketonuria: association with brain MRI, dietary state, and IQ.
Jones SJ; Turano G; Kriss A; Shawkat F; Kendall B; Thompson AJ
J Neurol Neurosurg Psychiatry; 1995 Sep; 59(3):260-5. PubMed ID: 7673953
[TBL] [Abstract][Full Text] [Related]
47. [Features of the convulsive activity in the EEG of patients with classic phenylketonuria].
Lastochkina NA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(3):79-86. PubMed ID: 6858502
[TBL] [Abstract][Full Text] [Related]
48. Twelve years of clinical experience with phenylketonuria. A statistical evaluation of symptoms, growth, mental development, electroencephalographic records, serum phenylalanine levels, and results of dietary management.
Fisch RO; Torres F; Gravem HJ; Greenwood CS; Anderson JA
Neurology; 1969 Jul; 19(7):659-66. PubMed ID: 5815130
[No Abstract] [Full Text] [Related]
49. [The maternal phenylketonuria syndrom--still current problem].
Didycz B; Domagała L; Pietrzyk JJ
Przegl Lek; 2009; 66(1-2):4-10. PubMed ID: 19485248
[TBL] [Abstract][Full Text] [Related]
50. [EEG findings during diet therapy of phenylketonuria].
Wässer S; Theile H; Graustein I; Bergmann L
Kinderarztl Prax; 1976 Aug; 44(8):344-7. PubMed ID: 966460
[No Abstract] [Full Text] [Related]
51. Physical growth in phenylketonuria: I. A retrospective study.
Holm VA; Knox WE
Pediatrics; 1979 May; 63(5):694-9. PubMed ID: 312489
[TBL] [Abstract][Full Text] [Related]
52. Event-related potential correlates of selective processing in early- and continuously-treated children with phenylketonuria: effects of concurrent phenylalanine level and dietary control.
de Sonneville LM; Huijbregts SC; van Spronsen FJ; Verkerk PH; Sergeant JA; Licht R
Mol Genet Metab; 2010; 99 Suppl 1():S10-7. PubMed ID: 20123462
[TBL] [Abstract][Full Text] [Related]
53. Assessment of adult phenylketonuria.
Cleary M; Walter JH
Ann Clin Biochem; 2001 Sep; 38(Pt 5):450-8. PubMed ID: 11587123
[TBL] [Abstract][Full Text] [Related]
54. The diagnosis of phenylketonuria: a report from the Collaborative Study of Children Treated for Phenylketonuria.
O'Flynn ME; Holtzman NA; Blaskovics M; Azen C; Williamson ML
Am J Dis Child; 1980 Aug; 134(8):769-74. PubMed ID: 7405915
[TBL] [Abstract][Full Text] [Related]
55. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
[TBL] [Abstract][Full Text] [Related]
56. [E.E.G. appearances in hyperphenylalaninaemia (author's transl)].
Moussalli-Salefranque F; Mises J; Cheynel A; Phelippeau M; Saudubray JM
Rev Electroencephalogr Neurophysiol Clin; 1978; 8(1):45-53. PubMed ID: 663348
[TBL] [Abstract][Full Text] [Related]
57. Intelligence and phenylketonuria: effects of diet termination.
Koff E; Kammerer B; Boyle P; Pueschel SM
J Pediatr; 1979 Apr; 94(4):534-7. PubMed ID: 430288
[TBL] [Abstract][Full Text] [Related]
58. Intellectual assessment of 111 four-year-old children with phenylketonuria.
Dobson JC; Williamson ML; Azen C; Koch R
Pediatrics; 1977 Dec; 60(6):822-7. PubMed ID: 600594
[TBL] [Abstract][Full Text] [Related]
59. [Clinical aspects of phenylketonuria].
Takati T; Oura T
Shinkei Kenkyu No Shimpo; 1968; 12(1):111-23. PubMed ID: 4881481
[No Abstract] [Full Text] [Related]
60. Neurophysiological, psychological, and nutritional investigations during discontinuation of the phenylalanine-restricted diet in children with classic phenylketonuria.
Pueschel SM; Fogelson-Doyle L; Kammerer B; Matsumiya Y
J Ment Defic Res; 1983 Mar; 27 (Pt 1)():61-7. PubMed ID: 6615595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
